Kinome-Wide Screening with Small Interfering RNA Identified Polo-like Kinase 1 as a Key Regulator of Proliferation in Oral Cancer Cells

Cancers
Yih-Gang GoanChih-Wen Shu

Abstract

Oral squamous cell carcinoma (OSCC) is one of the major leading causes of cancer-related death worldwide, with limited effective markers for diagnosis and therapy, which has caused a low overall survival rate in the past decades. Kinases play important roles in tumor development and malignancy in various types of cancer. However, little is known about the role of kinases in OSCC cells. In this study, an arrayed kinome small interfering RNA (siRNA) library was used to screen oral cancer cell lines and counter assayed with normal fibroblast cells to identify the genes required for cancer cell proliferation. We found that polo-like kinase 1 (PLK1) was one of the most potent genes required for OSCC cell proliferation. The knockdown of PLK1 with a siRNA or antisense oligonucleotide (ASO) consistently diminished cyclin-B1 (CCNB1) expression/phosphorylation and the G2-M phase transition. Similar effects were observed in cells treated with the PLK1 kinase inhibitor BI6727. Besides, The Cancer Genome Atlas (TCGA) analysis revealed that PLK1 was elevated in tumor tissues and associated with short survival in patients with OSCC. We also found that PLK1 expression was highly correlated with the expression of its downstream effector, CCNB1,...Continue Reading

References

Nov 10, 2000·Nucleic Acids Research·K KrauseK Engeland
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 10, 2011·The Journal of Pathology·Jonathan K Watts, David R Corey
Nov 26, 2011·Cell Death and Differentiation·M BartucciR De Maria
Apr 25, 2013·International Journal of Cancer. Journal International Du Cancer·Youwei Zhang, Tony Hunter
Sep 10, 2013·Cell Cycle·Khanh DoShivaani Kummar
Oct 22, 2013·Pharmacology & Therapeutics·S McNeelyA K Bence Lin
Dec 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Sree Vidya Krishna RaoRichard Logan
Jun 23, 2016·Molecular Cancer Therapeutics·Rosie Elizabeth Ann GutteridgeNihal Ahmad
Jul 19, 2016·Trends in Pharmacological Sciences·Christopher J MathesonPhilip Reigan
Aug 30, 2016·Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs·Jessica Chery
Nov 27, 2016·Translational Oncology·Zhixian LiuXiaosheng Wang
Apr 28, 2017·Cancers·Stuart RundleNicola J Curtin
Jun 20, 2019·Frontiers in Oncology·Jin-Shiung ChengChih-Wen Shu

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
Transfections
PCR
antisense oligonucleotide
electrophoresis
Assay
antisense oligonucleotides

Software Mentioned

Prism

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.